Evidence map›Paper›PMID 41735607›Full record

ArticleNature cell biology2026

LBR and LAP2 mediate heterochromatin tethering to the nuclear periphery to preserve genome homeostasis.

Renard Lewis, Virginia Sinigiani, Noura Maziak, Krisztian Koos, Cristiana Bersaglieri, Ivo Zemp, Caroline Ashiono, Constance Ciaudo, Peter Horvath, Juan M Vaquerizas and 3 more

Abstract read
In one paragraph

Article in Nature cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Renard LewisInstitute of Biochemistry, Department of Biology, ETH Zurich, Zurich, Switzerland.
Virginia SinigianiInstitute of Biochemistry, Department of Biology, ETH Zurich, Zurich, Switzerland.
Noura Maziak *MRC Laboratory of Medical Sciences, Hammersmith Hospital Campus, London, UK.
Krisztian Koos *Synthetic and Systems Biology Unit, Biological Research Center, Szeged, Hungary.ORCID http://orcid.org/0000-0003-3136-8978
Cristiana Bersaglieri *Department of Molecular Mechanisms of Disease, University of Zurich, Zurich, Switzerland.
Ivo ZempInstitute of Biochemistry, Department of Biology, ETH Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0003-1549-9871
Caroline AshionoInstitute of Biochemistry, Department of Biology, ETH Zurich, Zurich, Switzerland.
Constance CiaudoInstitute of Molecular Health Sciences, Department of Biology, ETH Zurich, Zurich, Switzerland.
Peter HorvathSynthetic and Systems Biology Unit, Biological Research Center, Szeged, Hungary.ORCID http://orcid.org/0000-0002-4492-1798
Juan M VaquerizasMRC Laboratory of Medical Sciences, Hammersmith Hospital Campus, London, UK.ORCID http://orcid.org/0000-0002-6583-6541
Raffaella SantoroDepartment of Molecular Mechanisms of Disease, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-9894-2896
Puneet SharmaInstitute of Biochemistry, Department of Biology, ETH Zurich, Zurich, Switzerland.
Ulrike KutayInstitute of Biochemistry, Department of Biology, ETH Zurich, Zurich, Switzerland. ulrike.kutay@bc.biol.ethz.ch.ORCID http://orcid.org/0000-0002-8257-7465

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) ERC-AdG-787074-NucleolusChromatinEC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) SWEEPICSRCUK | Medical Research Council (MRC) MC_UP_160510Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 310030_219203Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) TMAG-3_209245
6 · The paper itself

Abstract

In most eukaryotic cells, euchromatin is localized in the nuclear interior, whereas heterochromatin is enriched at the nuclear envelope (NE). This conventional chromatin organization is established by heterochromatin tethering to the NE; however, its importance for cellular homeostasis is largely unexplored. One tether is constituted by the lamin B receptor (LBR) in mammals, but the enigmatic nature of other redundant tethers has hampered functional analyses. Here we demonstrate that downregulation of abundant, ubiquitous NE proteins can induce the global detachment of heterochromatin from the NE and its repositioning to the nuclear interior. We identify LBR and lamina-associated polypeptide 2 (LAP2) as key factors for peripheral heterochromatin positioning in differentiated and pluripotent mammalian cells. Their long-term loss leads to changes in three-dimensional chromatin organization and a reduction in repressive epigenetic marks, especially H3K27me3. These changes are associated with massive deregulation of gene expression, activation of antiviral innate immunity, and defects in cell fate determination.

Indexed as

Cell NucleusDNA-Binding ProteinsGenomeHeterochromatinHomeostasisMembrane ProteinsNuclear EnvelopeReceptors, Cytoplasmic and NuclearAnimalsCell DifferentiationChromatin Assembly and DisassemblyEpigenesis, GeneticHistonesHumansLamin B ReceptorMiceDNA-Binding ProteinsHeterochromatinHistoneslamina-associated polypeptide 2Lamin B ReceptorMembrane ProteinsReceptors, Cytoplasmic and Nuclear

Identifiers

PMID41735607
PMCPMC12992122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.